START FREE TRIAL

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...

Eli Lilly Adverum Acquisition Could Reshape Gene Therapy!

Eli Lilly (NYSE:LLY) isn’t slowing down. After a quarter filled with blockbuster drug launches, accelerated global uptake of Mounjaro...

Mirum Bluejay Acquisition Unlocks Rare Disease Gold!

Mirum Pharmaceuticals (NASDAQ:MIRM) is making big moves. In early December 2025, the company announced its plan to acquire privately...

Novartis Gene Therapy Approval: A New Multi-Billion Dollar Market?

Novartis just scored a big win with a major Novartis gene therapy approval —and it could reshape the gene...

Abbott Exact Sciences Acquisition: $21B Cancer Gamble

Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...

Johnson & Johnson Halda Acquisition: The $3.05 Billion Gamble!

Johnson & Johnson just made another big move. The company announced that it will buy Halda Therapeutics for $3.05...

Merck Cidara Acquisition: $9.2B Flu Drug Deal to Replace Keytruda

Merck isn’t waiting around for Keytruda’s patent clock to run out. On November 14, the pharma giant announced its...

Cogent Biosciences’ Cancer Drug Exploded to 136% —Can the Rally Actually Last?

It’s not every day you see a biotech stock jump 136% before lunch. But that’s exactly what happened with...

Premier Inc. Draws Buyout Interest From Patient Square Capital — Here’s Why This Deal Could Happen

Premier Inc, a healthcare group purchasing and technology company, has recently become the subject of acquisition interest from private...

GE Healthcare’s Neurology Bet: Can The Icometrix Acquisition Unlock The Alzheimer’s Diagnosis Market?

GE HealthCare has deepened its push into precision medicine with a strategic agreement to acquire icometrix, a Belgium-based firm...

Jamf Holding’s $1.4 Billion Shakeup: Citigroup Tapped As Vista Plots Its Exit

Jamf Holding Corp., a leading Apple-focused device management and security software provider, has become the subject of renewed M&A...

Kenvue Crashing?—New RFK Jr. Report May Blame Tylenol Use In Pregnancy For Autism

Shares of Kenvue Inc., maker of Tylenol, dropped roughly 10% in early September 2025 after media reports—primarily from The...